HPV vaccine uptake among daughters of Latinx immigrant mothers: Findings from a cluster randomized controlled trial of a community-based, culturally relevant intervention

Vaccine
Volume 38, Issue 25 Pages 4057-4134 (22 May 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/25

 

Research article Abstract only
HPV vaccine uptake among daughters of Latinx immigrant mothers: Findings from a cluster randomized controlled trial of a community-based, culturally relevant intervention
Isabel C. Scarinci, Barbara Hansen, Young-il Kim

 

Socioeconomic Determinants in Vaccine Hesitancy and Vaccine Refusal in Italy

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 6 June 2020)

 

Open Access Article
Socioeconomic Determinants in Vaccine Hesitancy and Vaccine Refusal in Italy
by Chiara Bertoncello , Antonio Ferro , Marco Fonzo , Sofia Zanovello , Giuseppina Napoletano , Francesca Russo , Vincenzo Baldo and Silvia Cocchio
Vaccines 2020, 8(2), 276; https://doi.org/10.3390/vaccines8020276 (registering DOI) – 05 Jun 2020
Abstract
Childhood vaccination has been a milestone in the control of infectious diseases. However, even in countries offering equal access to vaccination, a number of vaccine-preventable diseases have re-emerged. Suboptimal vaccination coverage has been called into question. The aim was to explore socioeconomic inequalities […]

 

Media/Policy Watch

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 6 June 2020
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 6 June 2020
[No new, unique, relevant content]

 

The Economist
http://www.economist.com/
Accessed 6 June 2020
The world after covid-19
Jennifer Doudna on how covid-19 is spurring science to accelerate
A change is under way in the respect for scientists, dissemination of research and forms of collaboration
Jun 5th 2020… More than 150 therapeutic or vaccine candidates are now in clinical trials and hundreds more are in pre-clinical development…

Schumpeter
The quest for a vaccine could restore faith in big pharma
The boffins of AstraZeneca are showing the way forward
Jun 5th 2020… Until the coronavirus, the company barely dabbled in the $60bn-a-year vaccine business. Yet now he is leading the effort not just to create a …

 

Financial Times
http://www.ft.com/home/uk
Accessed 6 June 2020
[No new, unique, relevant content]
Bottom of Form

 

Forbes
http://www.forbes.com/
Accessed 6 June 2020
Breaking  |  
Jun 5, 2020
Trump Says U.S. Is ‘Ready To Go’ With 2 Million Coronavirus Vaccines Upon Approval
No vaccine candidate has been approved, but companies have already begun ramping up for production.
By Carlie Porterfield Forbes Staff

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 6 June 2020
Snapshot June 5, 2020
How to Keep the United States in the WHO
If carried out, withdrawing from the WHO would mark one of the most ruinous presidential decisions of modern history—a blow to global health security and to the rule of…
Harold Hongju Koh and Lawrence O. Gostin

 

Foreign Policy
http://foreignpolicy.com/
Accessed 6 June 2020 | [No new, unique, relevant content]
[No new, unique, relevant content]

 

The Guardian
http://www.guardiannews.com/
[No new, unique, relevant content]

 

New Yorker
http://www.newyorker.com/
Accessed 6 June 2020
[No new, unique, relevant content]

 

New York Times
http://www.nytimes.com/
Accessed 6 June 2020
Middle East
G20 Pledges More Than $21 Billion to Fight Coronavirus
The Group of 20 rich and emerging economies has pledged more than $21 billion to fight the coronavirus, the group said early on Saturday.
By Reuters June 5

Asia Pacific
Japan Aims to Have Coronavirus Vaccines in Use by June 2021
Japan aims to put coronavirus vaccines into use by June 2021, the health minister said on Friday, as the country strives to be fully ready to host the Tokyo Olympics, originally planned for this summer but postponed by one year due to the pandemic.
By Reuters June 5

Asia Pacific
Australia’s CSL Says to Help Fund, Make Vaccine Candidate if It Proves Successful
Australia’s biggest biotech firm CSL Ltd said it would help fund the development of a University of Queensland COVID-19 vaccine candidate and if it was successful, could make up to one hundred million doses towards the end of next year.
By Reuters June 4

Europe
AstraZeneca Targets Two Billion Doses, Poor Countries With COVID Vaccine Deals
British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries.
By Reuters

 

Washington Post
https://www.washingtonpost.com/
Accessed 6 June 2020
The biggest challenge for a coronavirus vaccine could be getting countries to share
William Wan and Carolyn Y. Johnson · Health · Jun 4, 2020

 

Think Tanks et al

Think Tanks et al

Brookings
http://www.brookings.edu/
Accessed 6 June 2020
Future Development
Developing countries can respond to COVID-19 in ways that are swift, at scale, and successful
Larry Cooley and Johannes F. Linn
Thursday, June 4, 2020

Center for Global Development [to 6 June 2020]
http://www.cgdev.org/page/press-center
Accessed 6 June 2020
India’s COVID-19 Testing Capacity Must Grow by a Factor of 10: Here’s How That Can Happen
Publication
6/4/20
Diagnostic testing is at the center of the policy debate around COVID-19 interventions in India. As of June 1, 2020, India had conducted approximately 3.8 million tests since it began testing in February, but many experts have noted that testing capacity is still drastically insufficient for the needs of the population.

Chatham House [to 6 June 2020]
https://www.chathamhouse.org/
Expert Comment
Equity, Trust and Accountability Vital in Preventing Pandemics
2 June 2020
COVID-19 has highlighted the common systemic weaknesses that have hindered the pandemic response in many countries, regardless of wealth or location.
Dr Mishal Khan. One Health Consultant, Global Health Programme

 

CSIS
https://www.csis.org/
Accessed 6 June 2020
Critical Questions
Strengthening Routine Immunizations and Responding to Covid-19
June 3, 2020 | By Katherine Bliss

 

Council on Foreign Relations
http://www.cfr.org/
Accessed 6 June 2020
[No new relevant content]

 

Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 6 June 2020
[No new relevant content]